Trump’s NIH Shake-Up: DEI Grants Resurrected

(DailyAnswer.org) – Billions in taxpayer-backed health research are being yanked back into the DEI pipeline after courts forced the NIH to undo Trump’s effort to steer money away from ideological projects and back toward core science.

Story Snapshot

NIH is reconsidering thousands of DEI and gender-identity–related grants worth roughly $783 million after losing in court.
Trump’s 2025 directives had stalled or terminated more than 2,000 awarded grants and frozen review of thousands more tied to DEI agendas.
Democratic attorneys general, unions, and advocacy groups used the courts to roll back anti-DEI criteria and restart the funding pipeline.
NIH is quietly stripping formal DEI mandates from future grants even as it restores many of the shelved projects under legal pressure.

How Trump’s NIH Course Correction Triggered a Legal Firestorm

Early in 2025, the returning Trump administration pushed NIH to stop treating diversity ideology as settled science and to redirect federal research dollars away from DEI branding and gender-identity–centric work. Internal guidance at the agency prohibited or deprioritized funding for proposals framed around diversity, equity, and inclusion, gender identity, and a cluster of related topics such as workforce diversity and vaccine hesitancy. That shift triggered large-scale delays, midstream cancellations, and a political backlash from progressive universities and advocacy groups.

Within months, NIH halted review of new applications in disfavored categories and terminated hundreds of existing awards that had already cleared the agency’s own peer-review process. Researchers working on projects tied to transgender health, LGBTQ+ health, environmental exposure, sexual-violence prevention, and similar themes suddenly received termination notices. For many institutions, the move disrupted multi-year hiring, training, and community-partner commitments, exposing how deeply DEI branding had become embedded in publicly funded biomedical programs during the Biden years.

The Courts Force NIH to Backtrack on Canceled Grants

Scientists, professional groups, unions, and a coalition of Democratic state attorneys general quickly sued, arguing that NIH had ripped up already-awarded grants for ideological reasons and without clear rules. A federal judge in Massachusetts concluded the terminations likely violated the Administrative Procedure Act and ordered NIH to restore more than 2,000 grants that had been abruptly cut. The ruling emphasized that the agency never clearly defined DEI even as it used the label to justify pulling funding, raising red flags about arbitrary decision-making.

Appeals followed in the First Circuit and then at the Supreme Court, which left many researchers with reduced funding while signaling serious legal doubt about the anti-DEI directives. Facing hostile rulings and the risk of ongoing uncertainty, the Trump administration and NIH agreed in late December 2025 to settlements with scientists and state attorneys general. Under those deals, NIH would reconsider thousands of frozen, denied, or withdrawn applications using its standard scientific review process and without applying the contested anti-DEI criteria, while plaintiffs agreed to drop their remaining claims.

Reopened Spigot: Thousands of DEI-Linked Grants Back on the Table

The scale of the reconsideration tells conservatives just how big the DEI footprint inside NIH had become. Supreme Court analysis in one of the cases referenced roughly $783 million in disputed funding tied to the 2025 directives, and the settlements cover more than 5,000 grants nationwide. As NIH began implementing the agreement at the end of 2025, it issued decisions on hundreds of previously shelved or denied applications in a matter of days, with at least 528 grants decided on the very day the attorneys-general settlement was filed.

Many of the reconsidered projects address issues progressives have aggressively framed through identity politics: HIV prevention in targeted populations, LGBTQ+ health, sexual-violence research, vaccine hesitancy, and workforce diversity initiatives. Civil-liberties groups and university leaders celebrated the settlements as a victory against what they call political interference in science. For conservative readers who want agencies focused on objective medicine rather than social engineering, the story is more complicated: courts compelled NIH to reopen the DEI spigot even after voters chose a president promising to rein it in.

NIH Quietly Pulls Back Formal DEI Mandates Going Forward

While legal pressure forced the agency to reconsider past decisions, NIH leadership is still repositioning future funding priorities away from explicit DEI branding. The agency has removed “Diversity Plans” and “Plans for Enhancing Diverse Perspectives” from funding-opportunity requirements, and officials say those documents, when already submitted, will no longer influence funding choices. Policy language on inclusion in clinical research is being narrowed to straightforward categories like women and racial or ethnic minority groups instead of broad equity and social-justice framing.

NIH Director Jay Bhattacharya has been blunt that many restored DEI-focused projects are on borrowed time. He has reportedly stated that grants revived under court order cannot be immediately cut but will not be renewed when their cycles end in 2026 because they no longer fit NIH’s priorities. That stance suggests a compromise shaped by the courts: honor existing legal commitments, but reset the long-term direction of federal health research so money follows scientific merit and measurable health outcomes rather than slogans about equity and identity.

For constitutional conservatives, the episode highlights both the promise and the limits of using executive power alone to drain entrenched ideologies from massive bureaucracies. Trump’s orders initially redirected NIH away from DEI, but entrenched interests, Democratic officials, and sympathetic judges pushed back, forcing a partial retreat on already-awarded grants. At the same time, the settlements and policy changes expose just how much of the federal research state had been repurposed into a vehicle for cultural agendas that voters never approved at the ballot box.